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Abstract
Background: During infection, dendritic cells (DCs) encounter pathogenic microorganisms that
can modulate their function and shape the T cell responses generated. During the process of T cell
activation, DCs establish strong, long-lasting interactions with naïve T cells.
Methods: Using a mouse malaria model, the interactions of DCs and naïve CD4+ T cells have been
analysed.
Results: DCs, either incubated in vitro with infected erythrocytes or isolated from infected mice,
are able to present exogenous antigens by MHC-II, but are not able to establish prolonged effective
interactions with naïve CD4+ T cells and do not induce T cell activation. It was also found that
effective T cell activation of naïve CD4+ T cells is impaired during late Plasmodium yoelii infection.
Conclusion: These data may provide a mechanism for the lack of effective adaptive immune
responses induced by the Plasmodium parasite.
Background
Dendritic cells (DCs) are antigen-presenting cells (APC)
that play a central role in both innate and adaptive
immune responses. To initiate T cell-dependent immune
responses to microbial infections, DCs phagocytose anti-
gens in peripheral tissues and migrate to the draining
lymph nodes, where they interact with antigen-specific T
cells. Maturation of DCs, involving up-regulation of the
major histocompatibility complex (MHC) and peptide
complexes and the costimulatory molecules at the surface,
is required to efficiently prime naïve T cells [1]. Upon mat-
uration, DCs reorganize their actin cytoskeleton, project-
ing long and motile membrane extensions, called
dendrites. The initial encounters between antigen-pre-
senting DCs and specific naïve T cells are characterized by
the directional projection of abundant membrane exten-
sions from the DC toward the naïve T cell, followed by
entrapping of the T cell within a complex net of mem-
brane extensions [2].
The activation of T cells by DCs during Plasmodium infec-
tion has been previously studied. Although different
effects have been described depending on the parasite
strain used, time after infection or subpopulation of DC
analysed, a number of reports found defective activation
of T cells [3]. These findings may be related with the low
parasite-specific T cell responses induced by human
malaria infections [4,5].
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This report shows that DCs from Plasmodium yoelii-
infected mice are able to present antigens associated with
MHC-II, but do not establish strong interactions with
naïve CD4+ T cells. Accordingly, it was also found that
activation of naïve CD4+ T cells is inhibited during late
malaria infections.
Methods
Parasites and mice
Plasmodium yoelii (non-lethal parasite line 17 XNL) sporo-
zoites were obtained from dissection of infected Anopheles
stephensi mosquito salivary glands. BALB/c (haplotype H-
2Kd), C57BL/6 (haplotype H-2Kb) and Swiss Webster mice
were purchased from Taconic (Germantown, NY).
DO11.10 transgenic mice expressing a TCR specific for an
epitope from chicken ovalbumin (OVA) on CD4+ T cells
were purchased from Jackson Laboratories (Bar Harbor,
ME).
Erythrocytes isolation and mice infection with P. yoelii-
infected erythrocytes
Plasmodium yoelii-infected erythrocytes were obtained
from infected Swiss Webster mice with >25% parasitemia.
P. yoelii-infected erythrocytes were washed three times
with PBS and separated from white blood cells by centrif-
ugation at 2,000 g. Uninfected erythrocytes were obtained
from non-infected mice in the same way. To induce
blood-stage infection, 4 × 106 P. yoelii-infected erythro-
cytes were injected i.v. into each mouse. Parasitemia was
measured on days 2, 5, 8, 10, 13 and 15 with values of 4,
12, 25, 45, 20 and 11%, respectively.
Preparation of DCs from mouse bone marrow and 
incubation with P. yoelii-infected erythrocytes
Primary cultures of immature DCs from BALB/c mice were
obtained by differentiation of bone marrow-derived pre-
cursors as described [6]. This preparation yields >90% of
DCs expressing the distinctive DC surface marker CD11c,
as well as MHC class I and II molecules [7]. Plasmodium
yoelii-infected erythrocytes from infected mice were sepa-
rated into schizont and non-schizont forms by centrifuga-
tion in Accudenz (Accurate Chemical & Scientific Corp,
Wertbury, NY) density gradient solution. Uninfected
erythrocytes were treated in the same way. DCs (106 cells/
ml) were incubated for 24 h with uninfected or P. yoelii-
infected erythrocytes at a 1:30 ratio (DCs:schizonts).
Then, co-cultures were incubated with erythrocyte lysis
buffer (155 mM NH4Cl, 1 mM KHCO3, 0.1 mM
Na2EDTA) for 5 min. When indicated, maturation of DCs
was induced after 24 h of incubation with erythrocytes by
addition  Salmonella enterica LPS (1 μg/ml) (Sigma, St.
Louis, MO).
Isolation of DCs from mice
CD11c+ DCs were purified from the spleens of groups of
three malaria-infected at different times during the infec-
tion and non-infected mice using anti-CD11c antibodies
bound to magnetic beads (Miltenyi Biotec, Auburn, CA).
The isolated cell population is >85% CD11c positive.
Monoclonal antibodies and flow cytometry
PE anti-CD4 (L3T4), FITC anti CD69 (H1.2F3), PE anti-
DO11.10 clonotypic TCR (KJ1-26) from BD Biosciences.
Cell preparations were analysed on a FACSCalibur ® (Bec-
ton Dickinson). Results are shown after subtraction of the
background with only the secondary antibody.
Antigen Processing and Presentation
Using specific antibodies: Bone marrow-derived DCs pre-
incubated for 24 h with uninfected or P. yoelii-infected
erythrocytes were incubated with 5 mg/ml OVA (Sigma)
or 50 μg/ml LACK for 5 h. After incubation, cells were
washed and incubated with LPS (1 μg/ml) (Sigma) for 16
h. Expression of MHC-peptides complexes was detected
by immuno-fluorescence with specific antibodies and
analyzed using FACSCalibur® (Becton Dickinson). Alexa
647 conjugated antibody 25-D1.16 specific for the OVA
peptide 257–264/Kb complex was provided by Dr. Jon
Yewdell (NIH, Bethesda, MD) [Porgador, 1997 #144].
The immunodominant Leishmania  LACK protein and
antibody 2C44 (Glaichenhaus, manuscript in prepara-
tion), which recognizes the LACK 156–173/I-Ad complex
(LACK sequence FSPSLEHPIVVSGSW) [Malherbe, 2000
#181] was provided by (Nicholas Glaichenhaus, Univer-
sité de Nice-Sophia Antipolis, Valbonne, France). FITC-
Avidin was from Sigma (St. Louis, MO). Using T-cell
hybridomas: the same procedure was used as in with
FACS except that only 0.5 mg/ml of OVA was used and
CD11c+ DCs from groups of three uninfected or P. yoelii-
infected mice at different times after infection were also
analyzed. After LPS addition, cells were fixed with 0.001%
glutaraldehyde for presentation of OVA peptide 257–264/
H-2b complex or 1% paraformaldehyde for OVA peptide
323–339/I-Ad  complex. Presentation of peptides-MHC
complexes was detected using T-cell hybridomas B3Z
(provided by Dr. Ronald Germain, NIH, Bethesda, MD)
for OVA epitope 257–264/H-2b complex and DO-11.10
(provided by Dr. John Kappler and Dr. Pippa Marrack,
Howard Hughes Medical Institute, Denver, CO) for OVA
epitope 323–339/I-Ad complex. 2 × 105 DCs of matching
haplotype were mixed with 105 T-cell hybridomas in 200
μl of media/well in a 96-well plate. Supernatant was col-
lected after 24 h and IL-2 secretion was measured by ELISA
(BD Biosciences).
DC-T cell contact
Bone marrow derived DCs previously incubated with
uninfected or P. yoelii-infected erythrocytes (see above)Malaria Journal 2008, 7:88 http://www.malariajournal.com/content/7/1/88
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and CD11c+ DCs from the spleens of groups of three
blood stage-infected mice were incubated or not with 10
μg/ml of LPS for 20 h before incubation with OVA peptide
323–339 (ISQAVHAAHAEINEAGR) (Biopeptide Com-
pany, San Diego, CA) at 37°C for 1 h. DC-T cell contact
was analysed by immunoflurescence, time-lapse video
microscopy and FACS as previously described [8]. For
immunofluorescence, DCs were washed twice with PBS
and immobilized on poly-L-lysine-coated coverslips for 5
min at room temperature (105 cells/coverslip). PBS was
then removed and replaced with complete medium and
the coverslips were incubated for 1 h at 37°C. For DC-T
cell conjugate formation, 105 naïve DO11.10 T cells iso-
lated from transgenic mice were loaded with CFSE (0.5
μM) and added to DCs and incubated at 37°C. Incuba-
tion was stopped after 30 min and coverslips were washed
five times with PBS and fixed with 1% paraformaldehyde
for 10 min. F-actin was stained using rhodamine-conju-
gated phalloidin (Molecular Probes) (1:500 in blocking-
permeabilization solution). F-actin is used to differentiate
DCs from T cells, as the later have much lower levels of F-
actin [8]. DC-T cell contact was reported as the number of
'engulfed' T cell per 100 DCs in each each coverslip. For
time-lapse video microscopy, chambers mounted on a
coverglass (Nalge Nunc International) coated with 105
DCs were placed on the microscope at 37°C. One minute
after addition of 105 naïve DO11.10 T cells images were
collected every 10 seconds for 20 min. Images were
acquired using a 60× oil immersion objective and a
Hamamatsu digital camera (Universal Imaging). For
FACS, pre-stained naïve DO11.10 T cells with 0.5 μM
CFSE and DCs with 1 μM of CellTracker™ Orange (Molec-
ular Probes) were mixed (1:1), spun for 3 min at 500 rpm
(4°C) and incubated at 37°C for 30 min. Contact was
stopped by transferring the tubes to ice. Analysis by FACS
was done immediately after and the results are expressed
as percentage of green-red events to total T cells.
Stimulation of naïve DO11.10 CD4+ T cells
Immature and mature bone marrow derived DCs previ-
ously incubated with uninfected or P. yoelii-erythrocytes
and CD11c+ DCs from the spleen of groups of three blood
stage-infected mice at different time points were incu-
bated or not with 10 μg/ml of LPS for 20 h before incuba-
tion with 10 μg/ml of OVA peptide 323–339 as above.
After washing, 2 × 105 DCs were incubated with 2 × 105
naïve CD4+ T cells in 96 wells plate. T cell activation was
measured as up-regulation of CD69 after 12 h of culture.
In vivo activation of naïve CD4+ T cells during malaria 
blood stage
In order to test the in vivo activation of naïve CD4+ T cells
during malaria blood stage, adoptive transfer of DO11.10
cells was performed. 1.6 × 106 naïve DO11.10 CD4+ T
cells from transgenic mice were labeled with CFSE (10 μM
for 45 min) and transferred (i.v.) into groups of three
uninfected or infected Balb/c mice 5 or 10 days after infec-
tion (sex and age of donor and recipient mice were
matched). Mice were immunized with 2 mg/mouse of
OVA emulsified in complete Freund's adjuvant (Sigma)
by i.p. injection 24 h after transfer. Proliferation and
expression of CD11a, CD62L and intracellular IL-2 was
determined in transferred CFSE+ CD4+ T-cells 3 days after
immunization by FACS. Control mice received the same
volume of adjuvant alone.
Ethical approval
Experiments performed with mice were approved by the
NYU Institutional Animal Care and Use Committee
(IACUC).
Results and Discussion
DCs present exogenous antigens in the context of MHC
class II molecules for the activation of CD4+ T cells. DCs
are also able to cross-present exogenous antigens in the
context of MHC-I molecules to activate CD8+ T cells. It
was determined whether MHC-II and MHC-I antigen
presentation was affected during infection with P. yoelii.
For this purpose, specific antibodies were used, that recog-
nize defined peptide epitopes bound to particular MHC
molecules. These antibodies do not recognize the antigen
or the MHC molecules alone and can be used to deter-
mine the presence of MHC-epitope bound complexes in
the surface of antigen presenting cells. To determine
MHC-I and MHC-II antigen presentation anti-OVA
epitope 257–264/H-2b  (25-D1.16) and anti-LACK
epitope 156–173/I-Ad  (2C44) antibodies were used,
respectively. Bone-marrow derived DCs were incubated
either alone, with uninfected or P. yoelii-infected erythro-
cytes for 24 h before addition of purified OVA or LACK
proteins for 5 h, followed by stimulation with LPS to
induce antigen presentation. It was observed that incuba-
tion with P. yoelii-infected erythrocytes inhibits presenta-
tion of exogenous antigens on MHC-I (Figures 1A and
1B), but not on MHC-II molecules (Figures 1C and 1D).
The activation of T cell hybridomas that recognize specific
OVA peptides in the context of MHC-I and II molecules
was used as an alternative method to determine antigen
presentation. The T cell hybridomas B3Z [9] and
DO.11.10 [10] recognize specific OVA peptides on MHC
class I (H-2b) and II (I-Ad), respectively. T hybridoma cells
are less dependent than primary naive T cells on costimu-
latory molecules and they can be activated by fixed anti-
gen presenting cells. Recognition of peptide-MHC
complexes by T hybridoma cells results in increased IL-2
secretion. DCs were incubated with uninfected or P. yoelii-
infected erythrocytes for 24 h before addition of purified
OVA proteins for 5 h. DCs were then fixed to prevent
secretion of cytokines and incubated with the differentMalaria Journal 2008, 7:88 http://www.malariajournal.com/content/7/1/88
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hybridomas for 24 h. Activation of hybridomas was deter-
mined by detection of IL-2 in the incubation medium. It
was found that DCs pre-incubated with P. yoelii-infected
erythrocytes activate the T cell hybridoma recognizing
OVA-MHC-II, but the activation of the hybridoma recog-
nizing OVA-MHC-I was significantly reduced. The activa-
tion of the hybridomas was dose dependent (Figures 2A
and 2B).
Maturation of DCs increases their capacity for antigen
presentation, since it increases the expression of MHC
molecules on the cell surface [1]. As expected, it was found
that the addition of LPS to induce maturation of DCs 5 h
after incubation with OVA, resulted in increased activa-
tion of both hybridomas recognizing OVA-MHC-I and II
(Figures 2C and 2D). The effect of pre-incubating DCs
with P. yoelii-infected or uninfected erythrocytes in anti-
gen presentation of OVA by MHC-I and MHC-II after
inducing maturation with LPS was analysed. It was again
observed that P. yoelii-infected erythrocytes inhibit the
activation of the hybridoma recognizing OVA-MHC-I, but
not OVA-MHC-II (Figures 2E and 2F).
The capacity of CD11c+  DCs isolated from P. yoelii-
infected mice to present antigens by MHC-II was ana-
lysed. It was found that that MHC-II antigen presentation
is maintained during the course of infection, but MHC-I
cross-presentation of exogenous antigens is inhibited
throughout the course of the disease (Figures 2G and 2H).
These results confirm previous observations [11] that
MHC-I antigen presentation is inhibited during Plasmo-
dium infections and indicate that DCs are able to process
and present exogenous antigens by MHC-II during P. yoelii
infections.
The initial encounters between antigen-presenting DCs
and specific naïve T cells include directional projection of
abundant membrane extensions from the DC toward the
naïve T cell and prolonged interactions between both [2].
To analyse whether Plasmodium interferes with this proc-
ess, the interactions between bone marrow derived DCs
pre-incubated with infected erythrocytes and naïve CD4+
T cells were first studied using time-lapse video micros-
copy. DCs were pre-incubated with uninfected or P. yoelii-
infected erythrocytes and incubated with naïve anti-OVA
Plasmodium yoelii-infected erythrocytes inhibit MHC-I but not MHC-II antigen presentation Figure 1
Plasmodium yoelii-infected erythrocytes inhibit MHC-I but not MHC-II antigen presentation. (A-D) DCs differen-
tiated in vitro were incubated alone (DC), with uninfected (DC+RBC), P. yoelii-infected erythrocytes (DC+iRBC) for 24 h 
before addition or not of purified OVA (5 mg/ml; A,B) or LACK (50 μg/ml; C,D) proteins for 5 h, followed by stimulation with 
LPS to increase antigen presentation. Cells were stained with antibodies recognizing (A,B) OVA epitope 257–264 bound to H-
2b (antibody 25-D1) or (C,D) LACK epitope 156–173 bound to I-Ad (antibody 2C44). (A,C) Representative examples of FACs 
histograms of DCs incubated with protein OVA (A) or LACK (C) proteins (thick lines) or control DCs (thin lines). (B,D) 
Results are expressed as the difference in mean fluorescent intensity (MFI) of protein incubated DCs minus control DCs in 
triplicated determinations. *, significant difference (P < 0.01) in the intensity compared with DCs incubated alone.
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DCs from P. yoelii-infected mice can process exogenous antigen for MHC class II presentation but not for MHC class I Figure 2
DCs from P. yoelii-infected mice can process exogenous antigen for MHC class II presentation but not for 
MHC class I. (A,B) DCs pre-incubated with uninfected (black circles) or P. yoelii-infected (white circles) erythrocytes for 24 h, 
were incubated with OVA at the indicated concentrations for 5 h. DCs were then fixed and incubated with hybridoma B3Z 
specific for OVA epitope 257–264/H-2b (MHC-I) (A) or hybridoma DO11.10 specific for OVA epitope 323–339/I-Ad (MHC-II) 
(B). (C,D) DCs were incubated with BSA (5 mg/ml; balck bars) as negative control or OVA (5 mg/ml; white bars) for 5 h before 
addition or not of LPS for 16 h. DCs were then incubated with B3Z (C) or DO11.10 (D) hybridomas for 24 h. (E-H) DCs 
alone, pre-incubated with uninfected or P. yoelii-infected erythrocytes (E,F) or CD11c+ DCs isolated from infected mice at dif-
ferent times during blood-stage infection (G,H) were incubated with OVA 5 mg/ml (white bars) or BSA 5 mg/ml as negative 
control (black bars) for 5 h before addition of LPS for 16 h. DCs were fixed and incubated with hybridoma B3Z (E,G) or hybri-
doma DO11.10 (F,H). After 24 h, secretion of IL-2 by hybridomas in the culture medium was detected by ELISA.
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CD4+ T cells isolated from transgenic mice (DO11.10) rec-
ognizing a specific OVA epitope. DCs were loaded with
the same peptide epitope (OVA 323–339) before addition
of T cells. DCs presenting antigen normally interact with
antigen-specific naïve T cells for long periods of time
(more than 5 min) with abundant membrane extensions
projected in the direction of the T cell [8]. Pre-incubation
of DCs with uninfected erythrocytes did not affect DC-T
cell interactions, as prolonged interactions with mem-
brane extensions were frequently found in the co-cultures
(Figure 3A and Additional file 1). In contrast, pre-incuba-
tion with P. yoelii-infected erythrocytes inhibits the capac-
ity of DCs to maintain prolonged interactions with
membrane extensions with naïve T cells (Figure 3B and
Additional file 2). Only short interactions without projec-
tion of membrane extensions were observed.
To perform a quantitave analysis of this phenomenon, the
formation of stable conjugates between antigen-present-
ing DCs and specific T cells was observed. Each cell type
population was labeled with a different fluorescent dye to
allow the determination of dual positives for both labels
that correspond to stable conjugates [8]. After a 30 min
co-incubation of equal numbers of DCs presenting the
ovalbumin epitope and the specific naïve anti-OVA CD4+
T cells formed stable conjugates where DCs 'engulf' T cells
(Figure 4A, upper panels), which are different from loose
contacts between these cells (Figure 4A, lower panel).
Time-lapse microscopic analysis of the interaction between DCs and T cells after pre-incubation with P. yoelii-infected erythro- cytes Figure 3
Time-lapse microscopic analysis of the interaction between DCs and T cells after pre-incubation with P. yoelii-
infected erythrocytes. DCs were differentiated in vitro and pre-incubated with uninfected (A) or P. yoelii-infected (B) eryth-
rocytes before loading with OVA peptide 323–339. Naïve DO11.10 T cells that are specific for this OVA epitope were isolated 
from transgenic mice and added to DCs. Individual pictures frames from movies (Additional file 1 and Additional file 2) showing 
DC-T cell interactions. Arrows indicate contacts between DCs and T cells. Time in min is indicated in each frame. Represent-
ative results from one of five independent experiments are shown.Malaria Journal 2008, 7:88 http://www.malariajournal.com/content/7/1/88
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Impaired ability of DCs to interact with and to prime naïve CD4+T cells Figure 4
Impaired ability of DCs to interact with and to prime naïve CD4+T cells. (A) Upper left panel shows a T-cell (green) 
'engulfed' by a DC (red). Lower left panel shows a T-cell in contact with a DC but not 'engulfed'. Right panels show the same 
microscopic fields in transmitted light. (A-C) DCs were differentiated in vitro and pre-incubated with uninfected (DC+RBC) or 
P. yoelii-infected (DC+iRBC) erythrocytes, followed or not by incubation with LPS. DCs were loaded with OVA peptide 323–
339 (black bars) or not (white bars) and incubated for 30 min with naïve DO11.10 T-cells labeled with CFSE (green). (D,E) 
CD11c+ DCs were isolated from P. yoelii-infected mice at different times of infection and incubated alone (white bars), with 
OVA peptide 323–339 (gray bars), or with LPS and OVA peptide 323–339 (black bars). DCs were incubated for 30 min with 
naïve DO11.10 T-cells labeled with CFSE (green). For microscopy analysis (A,B,D), DCs were fixed and actin was stained (red), 
for FACs analysis (C,E), DCs were labeled with cell tracker (red) before incubation with T-cells. (B,D) Number of 'engulfed' T-
cells per 100 DCs analysed by microscopy. (C,E) Percentage of DC-T-cell conjugates analysed by FACS. (F,G) Up-regulation of 
CD69 in naïve CD4+ T-cells after a12 h incubation with OVA peptide 323–339-loaded unstimulated (white bars) or LPS-stimu-
lated DCs (black bars). (F) DCs were differentiated in vitro and pre-incubated or not with uninfected or P. yoelii-infected eryth-
rocytes. (G) DCs were isolated from infected mice at different times during blood-stage infection. Results are expressed as 
mean ± SD of triplicate samples. FACs analysis for (F) and (G) data is shown in Additional File 3.Malaria Journal 2008, 7:88 http://www.malariajournal.com/content/7/1/88
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Quantification of the number of dual positives by fluores-
cence microscopy revealed that DC-T cell conjugates are
formed when control DCs loaded with the specific pep-
tide epitope are incubated with specific T cells and the
number of conjugates is increased when DCs had been
activated by addition of LPS. Pre-incubation of DCs with
P. yoelii-infected erythrocytes significantly inhibited the
formation of stable DC-T cell conjugates (Figure 4B).
Analysis of double positives for each fluorescent label by
FACs provided similar results (Figure 4C). Addition of LPS
as a maturation signal increased the number of DC-T cell
conjugates in the control DCs pre-incubated with unin-
fected erythrocytes, but did not improve DC-T cell interac-
tions impaired by P. yoelii-infected erythrocytes (Figures
4B and 4C).
When a similar analysis was performed using CD11c+ DCs
isolated from P. yoelii-infected animals at different times
after infection, we also found a significant decrease in the
numbers of DC-T cell stable conjugates compared to
uninfected mice (day 0). Even if lower, detectable levels of
stable conjugates formed by DCs from infected mice and
specific T cells were found by microscopy and FACs (Fig-
ures 4D and 4E), suggesting that DC-T cell interactions are
impaired but not completely inhibited by P. yoelii infec-
tion. These levels were minimally increased by addition of
LPS to DCs (Figures 4D and 4E).
To determine the level of T cell activation in the co-cul-
tures of DC and T cells, DCs were activated by addition of
LPS and the surface expression of the early activation
marker CD69 in T cells were analysed. In the co-cultures
of DCs incubated with P. yoelii-infected erythrocytes or
isolated from infected mice, the level of T cells expressing
CD69 was greatly decreased compared to co-cultures with
control DCs (Figures 4F and 4G).
To study the activation of CD4+ T-cells during P. yoelii
infection in vivo, naïve CD4+ T cells were transferred from
DO11.10 transgenic mice that are specific for the OVA
epitope 323–339 into P. yoelii-infected (day 10 p.i.) or
uninfected mice. Mice were immunized with OVA 24 h
after transfer and CD4+ T-cell activation was measured 72
h after OVA injection. Naïve CD4+ T-cells were fluores-
cently labeled before transfer to allow identification. The
number of transferred CD4+ T-cells in the spleen after 72
h was similar in uninfected and infected animals (Figure
5A), but after immunization with antigen, infected mice
primed transferred naïve CD4+ T-cells with lower effi-
ciency than uninfected mice. T-cell activation was lower in
infected mice as determined by proliferation (decrease in
CFSE labeling, Figure 5B), up-regulation of CD11a (Figure
5C), down-regulation of CD62L (Figure 5D) and
increased intracellular IL-2 (Figure 5E). The effect of trans-
ferring naïve CD4+ T cells from DO11.10 transgenic mice
into P. yoelii-infected mice earlier in infection (day 5), was
also analysed. Under these conditions, only proliferation
(decrease in CFSE labeling) and expression of CD11a
were significantly decreased in infected animals. No sig-
nificant changes were found in IL-2 secretion and expres-
sion of CD62L.
The capacity of DCs to provide adequate antigen presen-
tation to T cells in the context of P. yoelii infection was
analysed in detail. The results suggest that during P. yoelii
infections DCs maintain the ability to process and present
exogenous antigens by forming the MHC-II-epitope com-
plex in the surface of DC, however, as shown before for P.
berghei  [11], impaired cross-presentation of exogenous
antigens by MHC-I was found.
Efficient antigen presentation is not sufficient for the acti-
vation of naïve CD4+  and CD8+  T cells, which also
requires co-stimulatory signals from DCs and specific
cytokines [12]. The interactions of naïve T cells with
mature priming-inducing DCs are more stable than the
contacts with resting tolerance-inducing DCs. It has been
proposed that stable DC-T cell interactions participate in
the induction of antigen-specific T cell activation through
the delivery of an activatory signal by the DCs. In contrast,
unstable contacts with resting DCs might induce short-
term activation and proliferation signals in T cells [2],
which may explain the lack of T cell activation that we
observed during late malaria infection. In the absence of
mature DCs, serial unstable contacts between T cells and
resting DCs would result in T cell clonal deletion [2], a
phenomenon that has also been observed during malaria
infections, where there is specific deletion of T cells recog-
nizing Plasmodium antigens [13].
Maturation of DCs increases the duration of DC-T cell
interactions and allows the formation of a complex net of
membrane extensions in which DCs entrap T cells [8]. The
capacity of DCs to establish these effective interactions
with naïve CD4+ T cells was found to be inhibited during
infection. As actin-mediated reorganization of DC mor-
phology is required to form the strong, long-lasting inter-
actions with T cells [8], it is possible that the parasite may
interfere with the cytoskeleton of the DCs. In fact, numer-
ous genes in the DC cytoskeleton are modulated during P.
yoelii infection [14].
Previous studies have shown that DCs can process and
present antigens associated with MHC class II during
blood stage infections, suggesting that efficient activation
of CD4+ T cells could take place during murine infection
[15], however, defective activation and specific depletion
of CD4+  T cells recognizing Plasmodium  antigens is
observed during murine malaria infections [13,16]. Sup-
pression of OVA-specific CD4+ T cell proliferation has alsoMalaria Journal 2008, 7:88 http://www.malariajournal.com/content/7/1/88
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Activation of naïve CD4+ T-cells is impaired during late Plasmodium blood stage infection Figure 5
Activation of naïve CD4+ T-cells is impaired during late Plasmodium blood stage infection. DO11.10 naïve CD4+ T-
cells isolated from the spleens of transgenic mice were labeled with CFSE and transferred into uninfected or P. yoelii-infected 
mice (10 days after infection). Mice were immunized or not with OVA 24 h after transfer of T-cells. Three days after immuni-
zation, transferred CD4+ T-cells from spleens of recipient mice were analysed by FACs for (A) total number in the spleen, (B) 
proliferation (determined as decrease in CFSE fluorescence), (C) up-regulation of CD11a surface expression, (D) down-regula-
tion of CD62L surface expression, and (E) increase in intracellular IL-2 production. Results are expressed as the difference 
between values obtained with non-immunized versus OVA-immunized mice. Results are expressed as mean ± SD of triplicate 
samples. FACs analysis with the gates for transferred cells are shown in Additional file 4.Malaria Journal 2008, 7:88 http://www.malariajournal.com/content/7/1/88
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been observed in P. chaubaudi-infected mice, but in this
model inhibition was evident since early infection [17].
Furthermore, these authors also found that DC and CD4+
T cell interactions are inhibited by P. chaubaudi infection
in vitro and in vivo, while antigen presentation by MHC-II
is not affected [18].
Recently, two subpopulations of CD11c+ DCs with differ-
ential abilities to activate antigen-specific T cells have
been identified in P. chaubaudi infected mice [19], suggest-
ing that there may be a balance of opposing forces on the
host response. Since the interactions between DCs and T
cells are decreased, but are still detectable, it is possible
that we have observed the sum of different effects contrib-
uted by different subpopulations of DCs. It is currently
believed that tolerance of DCs, induced by exposure to
TLR ligands is induced during malaria infection [20]. In
this context, it is likely that tolerized DCs that are found
increasingly during late infection would have impaired
interactions with T cells leading to decreased activation.
Conclusion
In this work, it was observed that DCs isolated from
infected mice at different times after infection are not able
to establish strong interactions and prime naïve CD4+ T
cells. Protection generated by Plasmodium  infections
against blood-stage infection is mediated by helper and
effector functions of CD4+ T cells [21]. However, this T cell
response does not induce complete protection or long-
term immunity, suggesting that T cell activation or main-
tenance is impaired [22]. These results indicate that acti-
vation of naïve CD4+ T cells by DCs is impaired during
late malaria blood-stage infection in mice.
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T-cells. Three days after immunization, transferred CD4+ T-cells from 
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